Unmet needs in prostate cancer drug development and patient management are the ability
to monitor treatment effects and to identify therapeutic targets in a tumor at the time treatment …

The purpose of this article is to review the imaging techniques that have changed and are
anticipated to change bladder cancer evaluation. The use of multidetector 64-slice …

Since prostate-specific membrane antigen (PSMA) is up-regulated in nearly all stages of
prostate cancer (PCa), PSMA can be considered as a viable diagnostic biomarker and …

Tumor cells have an increased nutritional demand for amino acids (AAs) to satisfy their rapid
proliferation. Positron-emitting nuclide labeled AAs are interesting probes and are of great …

Context Molecular imaging (MI) entails the visualisation, characterisation, and measurement
of biologic processes at the molecular and cellular levels in humans and other living …

Study Type–Diagnostic (case series) Level of Evidence 4 What's known on the subject? and
What does the study add? The diagnosis of small renal masses (SRMs) has increased in …

The aim was to evaluate the efficacy of [18 F]-2-fluorodeoxyglucose positron emission
tomography/computed tomography (PET/CT) in evaluating metastasis of head and neck …

BACKGROUND Radioimmunoimaging with disease‐specific tracers can be advantageous
compared to that with nonspecific tracers for the imaging of glucose metabolism and cell …

Purpose To determine the performance accuracy of 18F-fluorodeoxyglucose positron
emission tomography/computed tomography (FDG PET/CT) after primary tumor treatment for …

Objective: To determine the diagnostic accuracy of 18 F-fluorodeoxyglucose (18 F-FDG)
positron emission tomography/computed tomography (PET/CT) for detecting metastasis and …